The FDA has granted breakthrough device designation to the RightEye Vision System, an oculomotor test to help diagnose Parkinson’s disease, RightEye LLC announced in a press release.

Parkinson’s disease is often misdiagnosed; however, research has shown that ocular tremors that prevent stability during fixation are often exhibited in patients with Parkinson’s. The RightEye Vision System is designed to identify these tremors, helping to diagnose the disease and detect it at an earlier stage, the release said.